Why are BRCA1 and BRCA2 significant in cancer biology?

Why are BRCA1 and BRCA2 significant in cancer biology?

• A. They are linked to skin cancer risk
• B. They are critical for regulating blood sugar levels
• C. They are tumor suppressor genes connected to breast and ovarian cancer
• D. They actively promote cell survival

Answer: (C)

BRCA1 and BRCA2 are significant in cancer biology primarily because they function as tumor suppressor genes that play essential roles in DNA repair processes. When either of these genes is mutated, the normal ability of cells to repair DNA damage is compromised, leading to an increase in genomic instability. This instability can result in the development of various cancers, most notably breast and ovarian cancer. Mutations in these genes have been associated with a hereditary form of breast and ovarian cancer, which helps explain why individuals with familial histories of these cancers are often tested for BRCA mutations. Identifying mutations in BRCA1 or BRCA2 can guide decisions about preventive measures, including increased surveillance, prophylactic surgeries, or chemoprevention strategies, thus highlighting their critical role not only in the biology of cancer but also in cancer risk management strategies. The other options are not relevant to the role of BRCA1 and BRCA2 in cancer biology. They do not have a direct link to skin cancer risk, are not involved in regulating blood sugar levels, and do not promote cell survival; rather, they help prevent uncontrolled cell growth by ensuring effective DNA repair.

BRCA1 and BRCA2 are significant in cancer biology primarily because they function as tumor suppressor genes that play essential roles in DNA repair processes. When either of these genes is mutated, the normal ability of cells to repair DNA damage is compromised, leading to an increase in genomic instability. This instability can result in the development of various cancers, most notably breast and ovarian cancer.

Mutations in these genes have been associated with a hereditary form of breast and ovarian cancer, which helps explain why individuals with familial histories of these cancers are often tested for BRCA mutations. Identifying mutations in BRCA1 or BRCA2 can guide decisions about preventive measures, including increased surveillance, prophylactic surgeries, or chemoprevention strategies, thus highlighting their critical role not only in the biology of cancer but also in cancer risk management strategies.

The other options are not relevant to the role of BRCA1 and BRCA2 in cancer biology. They do not have a direct link to skin cancer risk, are not involved in regulating blood sugar levels, and do not promote cell survival; rather, they help prevent uncontrolled cell growth by ensuring effective DNA repair.